Apr 4, 2026 · 1h 3m · news
How Hims & Hers Reached a $4.3BN Market Cap on $2.3BN of Revenue | Andrew Dudum · 20VC with Harry Stebbings
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this deep-dive interview, Hims & Hers founder and CEO Andrew Dudum discusses the company's trajectory to a multi-billion-dollar valuation, sharing strategic insights on navigating public markets, leveraging physical infrastructure alongside AI, and democratizing healthcare through a direct-to-consumer subscription model.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Harry holds 20.8% of the talking time here. How this is scored →
Harry as informed peer 4.4 Guest teaching 4.5 Guest disagreement 1.9 Harry pushing back 3.4
speaking balance: gold is Harry, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 13:13 Rejecting Single-Category Framing
Andrew explicitly rejects Harry's premise that weight loss represents 80% of revenue, pointing out how media narratives repeatedly mischaracterize Hims as a single-category business.
Hardest push from Harry ▶ 18:53 Challenging Wegovy Pricing ClaimsHarry directly confronts Andrew on Hims' affordability claims by citing actual list prices of $1,800 to $2,000 for Wegovy, forcing Andrew to clarify their direct partnership model.
Biggest teaching moment ▶ 46:10 Educating on Lipoprotein(a) Genetic MarkersAndrew educates Harry on critical genetic cardiovascular markers like lipoprotein(a), illustrating how standard medical panels miss vital preventative data that can alter life expectancy.
Harry holds his own ▶ 18:53 Citing Exact Pharma Market RatesHarry demonstrates strong industry knowledge by citing exact cash-pay and self-pay market prices for GLP-1 drugs to check Andrew's positioning on price leadership.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Harry as informed peer | Guest teaching | Guest disagreement | Harry pushing back | Why |
|---|---|---|---|---|---|---|
| The Reality of Running a Public Company | 4 | 3 | 2 | 3 | Harry challenges Andrew on why he enjoys running a public company despite public stock drops and online criticism. He cites the 'Six Flags' marketing strategy as an example of marketing by association. Andrew reframes public market pressure as a positive quarterly benchmark for high-performance teams. | |
| Hiring for Grit and Resilience | 3 | 4 | 2 | 2 | Harry asks about talent acquisition and references founder mode and executives like Ryan Petersen. Andrew explains his philosophy of avoiding hyper-credentialed corporate strategists in favor of gritty builders who have weathered operational crises. He emphasizes that leaders must replace themselves every twelve months with superior talent. | |
| Leveraging AI in Marketing and Clinical Operations | 3 | 4 | 2 | 3 | Harry presses Andrew on whether AI claims are exaggerated outside engineering and support. Andrew reframes the discussion by detailing how AI multiplies output in marketing ad creative iteration and standardizes care across thousands of clinical interactions. | |
| Hims & Hers' Multi-Category Portfolio Strategy | 4 | 5 | 3 | 3 | Harry asks if weight loss drugs represent 80% of revenue. Andrew firmly rejects the premise, explaining how media narratives historically mislabeled Hims as an ED-only or hair-only business, while it actually operates as a multi-category portfolio. | |
| Pricing, Partnerships, and Democratizing Care | 6 | 5 | 2 | 6 | Harry pushes back directly on Hims' pricing claims by bringing up $1,800 to $2,000 self-pay figures for GLP-1s. Andrew clarifies their recent Novo partnership pricing at $149 and details how Hims applies pressure to legacy pharmaceutical distribution models. | |
| The Defensibility of Physical Infrastructure Against AI | 5 | 5 | 3 | 3 | Harry asks whether OpenAI poses an existential threat to Hims' front-end consumer touchpoint, citing statistics from Monday.com. Andrew counters that physical infrastructure like a million square feet of pharmacy facilities and licensed medical professionals make Hims defensible against pure AI models. | |
| International Expansion and Aggressive Scaling | 5 | 4 | 2 | 4 | Harry brings up rumor metrics on international acquisitions like Eucalyptus and asks if rapid M&A causes operational anxiety. Andrew shares a rowing analogy, arguing that operating near the threshold of losing control is necessary to win. | |
| Brand Consistency and Defining Excellence | 4 | 5 | 1 | 3 | Harry cites Revolut's evolving stance on marketing and prompts Andrew on brand positioning. Andrew explains that successful brand building requires disciplined, repetitive messaging even when founders grow tired of repeating it. | |
| Preventative Diagnostics and At-Home Blood Testing | 5 | 6 | 1 | 3 | Harry proposes a hypothetical loss-leader model offering free diagnostic assessments to capture healthcare data, citing Gokul Rajaram's multi-product strategy. Andrew reveals Hims acquired YourBio Health to do exactly that using painless microneedle blood collection devices. | |
| Incentive Alignment and Systemic Disruption | 5 | 5 | 3 | 5 | Harry asks why Hims faces more negative media headlines than competitors like Ro. Andrew embraces the friction, explaining that true disruption of PBM and insurance distribution models naturally creates pushback from incumbent players. | |
| The Food Industry and the Obesity Epidemic | 4 | 3 | 0 | 2 | Harry criticizes the quality of processed food in the United States compared to Europe. Andrew agrees, contrasting French grocery standards with heavily processed US foods and discussing the economics of healthy eating for families. |
Statements from this episode (31)
Andrew Dudum: Running a public company is more fun than staying private
“I might be the only person that believes this, but I think running the company in the public markets is more fun than being private.”
Hims & Hers went public within 36 months of launching
“We went public really early. We went public after like I think, 36 months of launching, which was a little bit crazy.”
Founders should only go public with a 10-to-20-year commitment
“I think if your business is ready from an from a predictability standpoint, and you had a long-term orientation, then I would encourage you to go public. I think those two things have to be true. I think you have to actually be able to predict your business wi…”
Hiring non-startup corporate executives to scale is a mistake
“I think often people as they scale, maybe founders as they scale fall into the trap of trying to hire people that have seen bigger scale than them and are more strategic. And they feel like they've gotten to the point of success where now it's time where they …”
Leaders in growing companies must replace themselves every 12 months
“If you want to continue to scale in our organization or any organization that's growing, You have to realize that your job is changing every 12 months, right? To level yourself up to the next, next highest leverage focus area. In order to do that, you have to …”
Hims & Hers operates 1 million square feet of pharmacy fulfillment
“We operate about a million square feet of pharmacy fulfillment throughout the US.”
Hims & Hers spends $1 billion annually on marketing
“So we deploy about a billion dollars in marketing spend every year across the hims and hers brands.”
Hims & Hers treats over 10,000 patients daily
“So we treat, you know, 10,000 plus patients a day. We're probably the largest healthcare system in the U S. If you actually look at volume of patients treated. And now with recent markets, you know, definitely the largest globally from a digital health standpo…”
Weight loss is not the majority of Hims & Hers' revenue
“So weight loss is actually, you know, nowhere near the majority of this business. And I don't think ever will be just because you're continuing to expand core categories and a lot of new categories.”
Hims & Hers will not be first to market in peptides
“You won't see us be first to market in this category. You'll see us when we launch it, feel extremely confident in the clinical protocols, extremely confident in the guardrails, make sure that the supply chain and the quality is done to a level we are, you kno…”
GLP-1 drug prices dropped 80% in 18 months
“It's not something that's really happened in pharmaceutical history that the blockbuster drug of the century gets cut by 80% in 18 months.”
Standalone pharmacy fulfillment is not a valuable business model
“What I don't believe is that the pharmacy fulfillment part of our business independently is a particularly valuable business.”
Statins cost Hims & Hers two cents per dose to manufacture
“A statin is, you know, two cents for me to manufacture.”
Full-body MRI scan costs could fall to $300 annually
“A 500 K machine capitalized over a decade, you know, that the cost could come down to something like 300 dollars a year to do this test eventually.”
Physical infrastructure businesses are most defensible against AI models
“I think some of the most defensible businesses in the age of, you know, anthropic and open AI are businesses that actually do something physical. Like they require actual specialization and they require infrastructure.”
AI search growth has not significantly altered Hims customer acquisition
“You know, it hasn't had particularly dramatic changes since since, you know, some of these new AI companies have grown.”
Feeling close to losing control is what success feels like
“What I've found at least in running this business is, is if you don't feel like you are getting close to that line, you're probably not pushing hard enough. And so I do think That uncomfortable gut feeling where you're constantly questioning, constantly evalua…”
Launching commodity skincare and vitamins was a massive mistake for Hims
“So in the early years you know, I thought just having everything on the platform was how you win. And so we invested in, ah, skin care regiments, and we invested in vitamin supplements, and we invested in, you know, so many things that in retrospect were fairl…”
One-off brand marketing campaigns are a guaranteed way to lose money
“Like that's just like, it's a guaranteed way to just lose money. It's a great way to feel good. And it's super fun. It's like so much fun and we've done ton of it and it's really fun, but like, that's not a business strategy.”
Great brands repeat the same core message every week
“And in fact, what makes great brands great is the fact that everybody knows why they exist, why they fight, who their customer is, what the value is they deliver. And it's because they say the same damn thing in 20 different ways every single week.”
Hims & Hers acquired at-home blood device maker YourBio Health
“So last year we acquired your bio health, which is one of the few at home blood collection devices.”
Hims & Hers is spending hundreds of millions to verticalize labs
“And that requires us to spend hundreds of millions of dollars, which we're doing right now to totally verticalize this stuff and actually own the devices, the lab processing and that fulfillment.”
Hims & Hers offers lab testing essentially at cost
“Right, right now it's the lab testing offering. We offer it essentially at cost. We haven't verticalized any of this infrastructure, so it costs us, you know, pretty much just as much money as we sell it for.”
Most new Hims patients lack legacy EMR system data
“When you look at the patients coming to hims and hers today, the patients starting their healthcare journey, the majority of them do not have legacy data and systems within all DMR platforms.”
Andrew Dudum praises US administration for regulating processed foods
“I think the current administration is doing an amazing job on that issue. I really do. Right. Like the push to eat real food, the push to normalize the fact that all of the ingredients on these labels is garbage. It's chemicals. The push to educate people to a…”
Food industry is a primary cause of US obesity and mental health crises
“I think there's a huge problem with the food industry. I think the government applying pressure and regulation there is a wonderful idea for people because undoubtedly that's a massive part of the obesity epidemic in the country and also probably the mental he…”
Hims & Hers was a year or two too slow adopting AI
“I think I was too slow to force the company to invest in completely disrupting their team processes with AI... I think customer care, provider quality, all patient interactions. I think we were a year or two too slow on, on totally changing the model of how pa…”
Declining customer retention is far more dangerous than rising CAC
“There are always ways to optimize efficiency on acquisition. There are always new channels, new brand campaigns, new, new growth avenues. But if you don't have a sticky customer and for some reason they're becoming less sticky, your product market fit, your pa…”